Her scientific interests lie mostly in Cancer research, Genetics, Carcinogenesis, Genomics and Molecular biology. Her Cancer research research includes themes of Tumor suppressor gene, Signal transduction, microRNA and PTEN. The Signal transduction study which covers SETD2 that intersects with Chromatin and DNA methylation.
She studies Epigenetics which is a part of Genetics. Her Genomics research is under the purview of Genome. She has researched Genome in several fields, including Cancer and Gene expression profiling.
Lynda Chin mainly focuses on Cancer research, Genetics, Melanoma, Cancer and Gene. Her research integrates issues of Carcinogenesis, Tumor suppressor gene, Immunology, Signal transduction and PTEN in her study of Cancer research. Her Carcinogenesis research is multidisciplinary, relying on both Telomere and Molecular biology.
She studied Melanoma and In vivo that intersect with Apoptosis. Her Cancer research is multidisciplinary, incorporating elements of Genome instability, Oncology and Bioinformatics. She mostly deals with Locus in her studies of Gene.
Lynda Chin mostly deals with Cancer research, Cancer, Genetics, Gene and Genome. Her Cancer research study combines topics in areas such as Pancreatic cancer, Apoptosis, Immunology, microRNA and Neuroblastoma RAS viral oncogene homolog. Her research in microRNA intersects with topics in In silico, PBRM1 and Signal transduction.
Her research in PBRM1 focuses on subjects like Chromatin, which are connected to DNA methylation. Lynda Chin has included themes like Telomere, Oncology and Bioinformatics in her Cancer study. In Gene, Lynda Chin works on issues like Melanoma, which are connected to Mutation and Microphthalmia-associated transcription factor.
Her primary scientific interests are in Cancer research, Gene, Genetics, Melanoma and Genomics. The Cancer research study combines topics in areas such as Telomere, Cancer, microRNA and DNA methylation. Her Melanoma research is multidisciplinary, incorporating perspectives in Cell culture, Mutation, V600E, Clinical efficacy and Neuroblastoma RAS viral oncogene homolog.
The Mutation study which covers Regulatory sequence that intersects with Molecular biology. Her study in Genomics is interdisciplinary in nature, drawing from both Medical genetics, Computational biology, Synovial sarcoma and Gene expression profiling. The study incorporates disciplines such as Chromatin, SETD2, Signal transduction and Pancreatic cancer in addition to PBRM1.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
The cancer genome atlas pan-cancer analysis project
John N Weinstein;John N Weinstein;Eric A. Collisson;Gordon B Mills;Kenna R Mills Shaw;Kenna R Mills Shaw.
Nature Genetics (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler.
Malignant astrocytic glioma: genetics, biology, and paths to treatment.
Frank B. Furnari;Tim Fenton;Robert M. Bachoo;Akitake Mukasa.
Genes & Development (2007)
A landscape of driver mutations in melanoma
Eran Hodis;Ian R. Watson;Ian R. Watson;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov;Stefan T. Arold.
The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53
Jason Pomerantz;Nicole Schreiber-Agus;Nanette J. Liégeois;Adam Silverman.
Role of the INK4a locus in tumor suppression and cell mortality
Manuel Serrano;Han Woong Lee;Lynda Chin;Carlos Cordon-Cardo.
A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D. Pleasance;R. Keira Cheetham;Philip J. Stephens;David J. Mcbride.
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang;Franklin W. Huang;Eran Hodis;Eran Hodis;Eran Hodis;Mary Jue Xu;Mary Jue Xu;Mary Jue Xu;Gregory V. Kryukov.
Molecular characterization of the tumor microenvironment in breast cancer
Minna Allinen;Rameen Beroukhim;Li Cai;Cameron Brennan.
Cancer Cell (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: